Elegrobart is a subcutaneously-administered monoclonal antibody designed to target and inhibit the IGF-1 receptor, a key driver of thyroid eye disease.

Viridian Therapeutics (NASDAQ:VRDN) reported top-line results from its REVEAL-1 Phase III clinical trial evaluating ...

Please provide your email address to receive an email when new articles are posted on . Binocular diplopia was not an exceptional feature at GCA diagnosis. Diplopia resolution tends to be faster in ...

The list of possible causes of surgically induced postoperative diplopia is extensive. Retrobulbar and peribulbar injection have been reported to be associated with postoperative diplopia due to ...

With most previous studies on ocular myasthenia gravis stemming from investigations the neurology field, the present investigators came to their conclusion via neuro-ophthalmic analysis. In the ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A 64-year-old white man was seen in the ...

A 74-year-old woman was evaluated for ptosis and diplopia. She had noted the sudden onset of ptosis 2 months earlier, initially in the right upper eyelid and then a few days later in the left upper ...